Member Info for Bladderman

Last of the stock just under 3p getting taken out

Can buy on the bid at present

From BBC new masks compulsory in shops as second wave expected in the winter

Too many countries are headed in the wrong direction, says the head of the World Health Organization

The leaders of Houston, Texas, are calling for another statewide lockdown after infections there climbed to more than 27,600 on Sunday.

Should encourage the EUA to pull it's finger out too on a superior product compared to many

That's in accurate because the MM moved up the Ask and L2 shifted and bid strengthened in response

It's already fallen a long way. Why do you think someone just bought £77k in one hit.

If you don't like sell - it's simple. I'm expecting positive news flow from here on in

Clearly some folks here posting have sold out below 80p and expect to buy back in the 60s but if news lands

It's risky game doing that.

The sell was at 100p plus. Not low to mid 70s lol.

Each to their own

Made L2 light up on the Bid.

Wonder if this guy wants more...

Today at 16:21 it was printed- straight though

This is the GDR board Faz

Nice!!!

Someone expecting something then

Rainbow chasing on a share that has done 50% could mean one gets spiked. Could go either way

Under £40M and backed by Cytiva.

Buy zone

I'd say!!!

Great entry price. A new strategy for some should be buy here and sell 150p plus. Not buy over 150p and sell here!

Was a roll over trade so no idea whether a buy or sell

Yep 10% below placing price.

Many have bought high and sold low - that's not how to do it. IMO this is the buy zone before approvals land which can be anytime/anyday.

In terms of approval it is a formality for our product- to think EUA passed Ncyt with 80% sensitivity and ours is effective with 99%.

He's a lab manager in one of the largest regional diagnostic labs in the country i did say to him about our GDR product. He said it sounded good. But think they have lots of NCYT kits to get through. I will suggest that he could ask for a few sample PCR plates.

I do take comfort in the fact that our product kicks NCYT's ass (quicker turn round and simpler to use). We need to focus on Indian African and US (330M) population as that is where the money is for us.

*Re-test some samples.

Africa and indian countries require a robust (99% sensitive) superior test that is temperature stable so NCYT is not the product for them. They can't afford to be re-testing due to ambiguity.

My lab manager friend said he is not happy with NCYT product due to the increased work load of having to re-read one samples using other kits. Hopefully NHS as GDR as the product going forward.